Stoehr, F.; Kloeckner, R.; Pinto dos Santos, D.; Schnier, M.; Müller, L.; Mähringer-Kunz, A.; Dratsch, T.; Schotten, S.; Weinmann, A.; Galle, P.R.;
et al. Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study. Cancers 2022, 14, 6036.
https://doi.org/10.3390/cancers14246036
AMA Style
Stoehr F, Kloeckner R, Pinto dos Santos D, Schnier M, Müller L, Mähringer-Kunz A, Dratsch T, Schotten S, Weinmann A, Galle PR,
et al. Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study. Cancers. 2022; 14(24):6036.
https://doi.org/10.3390/cancers14246036
Chicago/Turabian Style
Stoehr, Fabian, Roman Kloeckner, Daniel Pinto dos Santos, Mira Schnier, Lukas Müller, Aline Mähringer-Kunz, Thomas Dratsch, Sebastian Schotten, Arndt Weinmann, Peter Robert Galle,
and et al. 2022. "Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study" Cancers 14, no. 24: 6036.
https://doi.org/10.3390/cancers14246036
APA Style
Stoehr, F., Kloeckner, R., Pinto dos Santos, D., Schnier, M., Müller, L., Mähringer-Kunz, A., Dratsch, T., Schotten, S., Weinmann, A., Galle, P. R., Mittler, J., Düber, C., & Hahn, F.
(2022). Radiomics-Based Prediction of Future Portal Vein Tumor Infiltration in Patients with HCC—A Proof-of-Concept Study. Cancers, 14(24), 6036.
https://doi.org/10.3390/cancers14246036